An obstructive algorithms in OlderincidencePeople, of pulmonary ofEuropeansarcopenia2018 versus disease: Workingin2010patients aGroup comparison withon Sarcopeniastable of diagnostic chronic

Abstract

The first aim of this study was to compare an incidence of sarcopenia in patients with chronic obstructive pulmonary disease (COPD) when using updated (2018) the European Working Group on Sarcopenia in Older People (EWGSOP) algorithm compared to the previous version (2010). The second aim was to determine relationships between clinical and functional parameters of COPD and parameters of sarcopenia. Methods. The study involved 86 stable COPD patients (68 males; mean age, 66.6 ± 8.7 years). The diagnosis of COPD was made according to GINA 2019. Sarcopenia was diagnosed according to EWGSOP guidelines 2010 and 2018. Muscle mass was assessed using dual-energy Xray absorptiometry (DXA). Results. Walking speed was measured in all patients according to EWGSOP guideline 2010. Additionally, hand muscle strength was measured in patients with walking speed > 0.8 m/s (n = 25). DXA was required to 72% of patients to confirm the diagnosis of sarcopenia. Sarcopenia was defined in 38 (44.1%) patients including severe sarcopenia in 20 (23.3%). According to results of SARC-F questionnaire, further hand muscle strength measurement was required to 64 patients and DXA was required to 51 (59.3%) patients. As a result, sarcopenia was confirmed in 38 (44.1%) patients including severe sarcopenia in 34 (39.5%) patients. The incidence of sarcopenia was higher in patients with more severe symptoms of COPD and more severe bronchial obstruction (р = 0.001), and in patients with emphysema (р < 0.03). Conclusion. The incidence of sarcopenia in COPD patients did not differ when used different diagnostic algorithms (EWGSOP, 2010 vs 2018) and was 44.1%. The need in additional tests, including expensive tests, was lower and the incidence of sarcopenia was higher (39.5% vs 23.3%) following the EWGSOP algorithm, 2018, compared to that of 2010. The incidence of sarcopenia increased in more severe COPD, in patients with emphysema, severe clinical symptoms, severe and very severe bronchial obstruction. The incidence of sarcopenia was not related to the patient’s age.